written by reader Mannkind

By bigkahuana, April 25, 2014

Doc Gumshoe, any thoughts on the inhaled insulin that Mannkind MNKD has and is about to be voted on for FDA approval in July. Seems to me that this is a blockbuster grug for a small company that could make the stock take off. Your opinion would be highly appreciated as I’m ready to buy this stock now but am trying to get a better grip on the potential of this drug.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

5 Comments
Inline Feedbacks
View all comments
omcdac1
omcdac1
6 years ago

Mannkind is not making or bringing anything blockbuster. Yes stock can take off for some time.
But it is not something like BNIKF that is real blockbuster. Dr Kss is talking about BNIKF for 3 months now. That is going to be real winner.

Add a Topic
5971
Add a Topic
3932
πŸ‘ 468
omcdac1
omcdac1
6 years ago

I had asked the same question from Dr kss about mankind. He doesn’t own MNKD.

Add a Topic
3932
πŸ‘ 468
R.Neman
R.Neman
6 years ago

MNKD can go either way. depends on FDA approval. Can go low as $6.00or as high as $16.00

Add a Topic
3022
stsparky
stsparky
6 years ago

They’ve a foreign partner now. I’m hoping higher than $20.

πŸ‘ 3
Elliot
6 years ago

I think most of Mannkind’s value lies in the Technosphere platform. I’m not convinced Afrezza will ever gain significant adoption, but I hold a small number of shares because I believe Technosphere could be huge some day, particularly for things like inhaled pain treatment and inhaled erectile dysfunction treatment, if ever pursued.

πŸ‘ 502

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info